Exchange: NASDAQ·Updated 07:52 PM EDT
HCWB logo

HCWB HCW Biologics Inc

$1.60
$0.07
(4.58%)
Today
Closed $1.60
$0.07
(4.38%)
After Hours
Reported EarningsAug 14
Mkt Cap$3.42M
Vol79,975.00

About HCWB

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
48

Neutral Sentiment

How do you feel about HCWB?

TheTinyDevil
$HCWB Two big spikes, consolidated, starting to curl, spread getting interesting... that's kind of the setup for another pop, no?
3
Stock_Catcher
$HCWB HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
1
Stock101010
$HCWB Based on limited Wall Street coverage, the consensus rating is a Buy/Strong Buy with a 12-month average target of $30.00 (implying a massive theoretical upside from current micro-cap levels). This must be a joke🙂, if this is true, that will be interestig to watch . The average 12-month price target for HCW Biologics (HCWB) is approximately $30.00, though forecasts vary widely depending on the analyst or model. I decided to buy very small amount , in other words lottery ticket. I like this kind of stock🙂👍. Good luck with trading 👍.
1
Joe_088
$HCWB HCW Biologics kept its IND filing timeline for HCW11-018b on track for 1H 2027, targeting a first-in-human solid-tumor study. A recent FDA Type B meeting provided guidance on remaining steps to support the IND package. Clinical-grade cGMP manufacturing is underway for trial supply. HCW11-018b combines a tissue factor-targeting, CD3-engaging BiTE design with IL-15 signaling and a TGF-β trap to counter tumor immunosuppression.
Joe_088
$HCWB For the one-year price torecasts, the average price target is 48.00 with a high estimate of 48.00 and a low estimate of 48.00. Updated on 10/02/2026
SpanishSpolied75
$HCWB New dilution is into street. If you don't want 2,5M stocks for me then 2,5 for Armistice..... Vote AGAINST in next Proxy. if we let aproved street we'll let our diluted money in Board hands..
ZeusPanda
$HCWB insiders in the company bought at $3 in july. this is a short time gift for you. small private placement. news coming
Jack345KY2
$HCWB the longer the halte the higher it will go will get out as soon as opens when ever that is
SpanishSpolied75
$HCWB "If you vote on proposal 1 regarding Armistice's 600K warrants, you leave them locked up and the Short Squeeze is going to go through the roof... Your voting power is 93%... Your gains... In the clouds...
SpanishSpolied75
$HCWB 🧠 The Quorum Trap in $HCWB :Insiders explicitly slashed the meeting quorum from 50% down to 33.33% (SEC Ex 3.2). They only hold 2.03% and Armistice has 4.99% (7.02% total). They CANNOT pass Prop 1 alone.They rely on retail apathy to hit that lower quorum. Vote AGAINST! 🛡️🗳️
The_Baba_Yaga
$HCWB Crazy daily, almost back at 52w lows. Ripped to $23.94 previously back on May 20th this year. I could see this having a big run again 📈

Advertisement|Remove ads.